VanEck Uranium and Nuclear Technologies UCITS ETF

The Product's investment objective is to replicate, before fees and expenses, the MarketVector Global Uranium and Nuclear Energy Infrastructure Index (the "Index"). In order to seek to achieve its investment objective, the Manufacturer will normally use a replication strategy by investing directly in the underlying securities of the Index being the equity stock, American depository receipts (ADRs), global depository receipts (GDRs) and closed-ended exchange-listed Products which qualify as transferable securities and fulfil further requirements as outlined in the Prospectus. Such securities must be issued by companies who generate at least 50% of their revenues from uranium (including uranium mining, or mining projects that have the potential to generate at least 50% of their revenues from uranium when developed), or with at least 50% of their revenues from nuclear energy infrastructure. For the avoidance of doubt, where the Index already holds such equity securities, the Index will seek to remove the security when the percentage of revenue generated from the uranium segment drops below 25% of the relevant companies revenues and from the nuclear energy segment to 0% of the relevant companies revenues. Where it is not practical or cost efficient for the Product to fully replicate the Index, the Manufacturer may utilise an optimized sampling methodology. The Product may invest up to 15% of its Net Asset Value directly in shares issued by companies listed on the Shanghai Stock Exchange or the Shenzhen Stock Exchange. The Product may invest more than 20% of its Net Asset Value in emerging markets. The Product may also (or alternatively) invest in financial derivative instruments (FDIs) which relate to the Index or constituents of the Index. The FDIs which the Product may use are futures, options (puts and calls), swaps (including equity swaps and swaps on the Index), currency forwards and non-deliverable forwards (a forward contract that does not require settlement on

Physical replication

PIR compliant

No

PEA compliant

No

PEA-PME compliant

No